Thomas Helledays forskargrupp
Målet med vår forskning är att förbättra cancerbehandling genom att utnyttja cancercellernas defekter för att skräddarsy specifika behandlingar för alla typer av cancer med minimala biverkningar.
Mer information finns på den engelska sidan.
Besöks- och postadress:
Helleday group
SciLifeLab A5
Tomtebodavägen 23a
171 65 Solna
Gruppmedlemmar
Ana Slipicevic, Project leader
Ann-Sofie Jemth Principal researcher and Team Leader Biochemistry and In Vitro Pharmacology
Athina Pliakou Research coordinator
Carina Norström Research engineer
Elisee Wiita Research engineer
Emilio Guillen Mancina postdoc
Evert Homan Senior research specialist
Helge Gad Senior researcher
Ingrid Almlöf Research engineer
Jianjyu Shen PhD student
Kumar Sanjiv Principal researcher and Team Leader In Vivo Pharmacology
Maeve Long Postdoc
Mari Kullman Magnusson Lab manager
Martin Henriksson Research engineer
Martin Scobie Research engineer
Maurice Michel Assistant Professor and Lead Enzyme Catalysis
Niklas Schultz Senior researcher
Oliver Mortusewicz Principal researcher and Team Leader Basic Science
Olov Wallner Research engineer and Team Leader Medicinal chemistry
Petra Marttila PhD student
Therese Pham Research engineer
Thomas Helleday Professor, PI
Viktoriia Tsuber Research specialist